Filing Details
- Accession Number:
- 0001225208-10-024003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-02 17:04:57
- Reporting Period:
- 2010-11-01
- Filing Date:
- 2010-11-02
- Accepted Time:
- 2010-11-02 17:04:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1405197 | Talecris Biotherapeutics Holdings Corp. | TLCR | Pharmaceutical Preparations (2834) | 202533768 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1472129 | Jr R Stephen Petteway | 4101 Research Commons 79 T.w. Alexander Drive Research Triangle Park NC 27709 | Executive Vp, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-11-01 | 20,000 | $1.39 | 80,198 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-11-01 | 25,000 | $24.37 | 55,198 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options (right to buy) | Disposition | 2010-11-01 | 20,000 | $1.39 | 20,000 | $1.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 309,040 | 2006-04-01 | 2015-11-10 | No | 4 | M | Direct |
Footnotes
- The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2010.
- The number of shares reported includes restricted share units representing the right to receive 9,210 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.28 to $24.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The option is fully vested and immediately exercisable.
Billionaire Hedge Funds
